Cerevel

Tony Coles takes second neuroscience startup public as Yumanity reverse merges
Endpoints
Mon, 08/24/20 - 10:17 am
Tony Coles
Cerevel
Yumanity Therapeutics
cystic fibrosis
Proteostasis Therapeutics